MS

Mohan Singh

Active Director Director DIN 09025134
DIN 09025134 First appointment Jan 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Jan 2021
Shareholding value Locked Premium profile

About Mohan Singh

Mohan Singh has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Alfatech Drugs Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 09025134
Primary Designation Director
First Appointment 09 Jan 2021
Oldest Company Age 5 yrs

Current companies

Company Designation Appointment Founded Status
Alfatech Drugs Private Limited U24230HR2021PTC092117
Director 09 Jan 2021 2021 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alfatech Drugs Private Limited
Premium access

Shareholding and investment profile for Mohan Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mohan Singh

Mohan Singh has 5 years in corporate governance. Holds Director role. Currently with 1 company, including Alfatech Drugs Private Limited. Engaged in Technology. Contributes to corporate operations.

Mohan Singh is associated with 1 company as Director.

Mohan Singh has expertise in Technology.

Mohan Singh has 5 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available